- Report
- February 2025
- 200 Pages
Global
From €3979EUR$4,490USD£3,427GBP
- Report
- September 2022
- 152 Pages
Global
From €6646EUR$7,500USD£5,724GBP
Antabuse is a drug used to treat alcohol use disorder (AUD). It is a form of aversive therapy, which works by causing unpleasant physical reactions when alcohol is consumed. It is a disulfiram-type medication, which blocks the body's ability to metabolize alcohol, leading to an accumulation of acetaldehyde in the bloodstream. This causes a range of unpleasant physical reactions, such as nausea, vomiting, headaches, and flushing. Antabuse is used as an adjunct to other forms of treatment, such as psychotherapy and counseling, to help people with AUD reduce their alcohol consumption and maintain abstinence.
The Antabuse market is a subset of the larger Addiction Disorders Drugs market. It is a relatively small market, but it is growing as more people seek treatment for AUD. Antabuse is a popular choice for those who are unable to abstain from alcohol without assistance.
Companies in the Antabuse market include Mylan, Teva Pharmaceuticals, and Accord Healthcare. Show Less Read more